Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison J Moskowitz

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Current Hematologic Malignancy Reports|July 31, 2019
The Role of PI3K Inhibition in Lymphoid MalignanciesGottfried von Keudell, Alison J Moskowitz
The Oncologist|September 10, 2009
Controversies in the treatment of lymphoma with autologous transplantationAlison J Moskowitz, Craig H Moskowitz
Blood|July 18, 2015
mTOR inhibition in T-cell lymphoma: a path(way) forwardAlison J Moskowitz, Steven M Horwitz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curveMatthew A Lunning, Alison J Moskowitz, Steven Horwitz
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Relapsed and Refractory Classical Hodgkin Lymphoma: Keeping Pace With Novel Agents and New Options for Salvage TherapyAlison J Moskowitz, Alex F Herrera, Anne W Beaven
Blood|March 12, 2014
How I treat the peripheral T-cell lymphomasAlison J Moskowitz, Matthew A Lunning, Steven M Horwitz
Cancer Journal (Sudbury, Mass.)|September 26, 2012
Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for longAlison J Moskowitz, Matthew A Lunning, Steven M Horwitz
Blood|February 2, 2024
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)Alison J Moskowitz, Robert N Stuver, Steven M Horwitz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Immunotherapy of Lymphoma and Myeloma: Facts and HopesMatthew J Pianko, Alison J Moskowitz, Alexander M Lesokhin
Cancer Treatment and Research|January 1, 2019
Angioimmunoblastic T-Cell LymphomaMariko Yabe, Ahmet Dogan, Steven M Horwitz, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Current Hematologic Malignancy Reports|July 31, 2019
The Role of PI3K Inhibition in Lymphoid MalignanciesGottfried von Keudell, Alison J Moskowitz
The Oncologist|September 10, 2009
Controversies in the treatment of lymphoma with autologous transplantationAlison J Moskowitz, Craig H Moskowitz
Blood|July 18, 2015
mTOR inhibition in T-cell lymphoma: a path(way) forwardAlison J Moskowitz, Steven M Horwitz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curveMatthew A Lunning, Alison J Moskowitz, Steven Horwitz
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Relapsed and Refractory Classical Hodgkin Lymphoma: Keeping Pace With Novel Agents and New Options for Salvage TherapyAlison J Moskowitz, Alex F Herrera, Anne W Beaven
Blood|March 12, 2014
How I treat the peripheral T-cell lymphomasAlison J Moskowitz, Matthew A Lunning, Steven M Horwitz
Cancer Journal (Sudbury, Mass.)|September 26, 2012
Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for longAlison J Moskowitz, Matthew A Lunning, Steven M Horwitz
Blood|February 2, 2024
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)Alison J Moskowitz, Robert N Stuver, Steven M Horwitz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Immunotherapy of Lymphoma and Myeloma: Facts and HopesMatthew J Pianko, Alison J Moskowitz, Alexander M Lesokhin
Cancer Treatment and Research|January 1, 2019
Angioimmunoblastic T-Cell LymphomaMariko Yabe, Ahmet Dogan, Steven M Horwitz, et al.
Pageof 10